Article | May 3, 2019

Grifols New Manufacturing Facility Provides Contract Development And Manufacturing Solutions For Recombinant Proteins

Source: Grifols Recombinant Protein CDMO Services

A Q&A with Paul Magreta from Grifols

Grifols CMF pic

Grifols' Consolidated Manufacturing Facility (CMF) is a flexible, multiproduct facility with available manufacturing capacity that created an opportunity to leverage their existing technical expertise and commitment to quality to provide contract services to biopharma companies as a recombinant protein CDMO and support the development of innovative therapies. We recently spoke with Paul Magreta at Grifols about their new $80 million manufacturing facility in Emeryville, California, and the CDMO Services they offer. 

Grifols Recombinant Protein CDMO Services